Topica Pharmaceuticals is a clinical research stage company focused on developing luliconazole for the treatment of onychomycosis, a common nail fungal infection affecting over 35 million Americans. Luliconazole has shown potent anti-fungal properties and a favorable safety profile, with the ability to penetrate the nail plate effectively. The company completed a Phase 1/2a clinical trial in 2011, demonstrating the swift nail plate penetration and patient tolerance of a 10 percent luliconazole solution. With its last $31.52M Venture Round investment in June 2013, Topica Pharmaceuticals is now dedicated to conducting dose-finding and efficacy studies, aiming to introduce luliconazole as the first highly effective and safe topical therapy for onychomycosis. The company operates in the Biotechnology, Medical Devices, and Pharmaceutical industries and was founded in 2004.
Topica Pharmaceuticals
Developing the first highly effective and safe topical therapy for onychomycosis.
General Information
BounceWatch is an independent company data service, not affiliated with Topica Pharmaceuticals. To contact Topica Pharmaceuticals, visit topicapharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About Topica Pharmaceuticals
Taxonomy: pharmaceuticals, clinical research, topical therapy, luliconazole, onychomycosis treatment, fungal infections, nail care, drug development, clinical trials, safety profile, anti-fungal activity, dose-finding studies, efficacy studies, medical innovation
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $31.52M | - |
|
10 Jun 2013 |
| Series B | $27.00M | 3 |
|
18 Oct 2011 |
| Series A | Undisclosed | - |
|
10 Sep 2010 |
Topica Pharmaceuticals Alternatives & Competitors
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serio...
Unparalleled in Passion & Purpose
Next Generation Anti-Infectives: A drug platform confirmed by independent labs to destroy all tested...
FAQ About Topica Pharmaceuticals
Source: BounceWatch company record for Topica Pharmaceuticals, https://bouncewatch.com/company/topica-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.
